Navigation Links
Henry Schein's Chairman and CEO Addresses the World Economic Forum
Date:2/1/2012

MELVILLE, N.Y., Feb. 1, 2012 /PRNewswire/ -- Stanley M. Bergman, Chairman and Chief Executive Officer of Henry Schein, Inc. (NASDAQ: HSIC), the largest provider of health care products and services to office-based practitioners, discussed the potential global impact of a world without effective antibiotics before an audience of business, political, academic and other leaders of society at the World Economic Forum's annual meeting in Davos-Klosters, Switzerland.  Mr. Bergman participated in a public session on January 27 entitled, "What if all known antibiotics lost their effectiveness?" moderated by Tan Chorh-Chuan, President, National University of Singapore.  Mr. Bergman appeared on this panel with other leaders from academia, government, and private industry.

Mr. Bergman's remarks highlighted the global public health, economic, and social ramifications of the hypothetical scenario of a world without effective antibiotics.  He discussed the role of the health care industry in response to this type of scenario, including the challenges of likely supply chain breakdowns and major business impacts, noting that these are similar to the challenges that come into play in society's response to natural disasters and pandemics, and the very issues that Henry Schein Cares, the Company's global corporate social responsibility program, is working hard to overcome through collaborative public-private partnerships.  The World Economic Forum a very effective platform for this public-private partnership collaboration.  To prevent this disastrous hypothetical scenario, Mr. Bergman called for the strengthening of public-private collaboration to promote the appropriate use of antibiotics, promotion of vaccines as an excellent antibiotic resistance prevention tool, and vigorous support for research and development to create new and better antibiotics.

'/>"/>
SOURCE Henry Schein, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Innovative Dental Education Initiative From Henry Schein, ADA And ADEA To Be Featured At ADA Annual Session In Hawaii
2. Henry Schein to Present at the Deutsche Bank Small and Mid Cap Conference
3. Henry Schein to Present at the UBS 20th Annual Global Healthcare Services Conference
4. Henry Schein To Present At The Jefferies 2010 Global Healthcare Services Conference
5. Henry Schein Elects Dr. Bradley T. Sheares to Board of Directors
6. Henry Schein Works With Supplier Partners to Earmark $1 Million in Health Care Supplies for Haiti Earthquake Relief
7. Henry Schein to Present at the NASDAQ OMX 23rd Investor Program
8. Henry Schein Announces New Strategic Partnership With Brain-Pad(R)
9. Henry Schein Announces the Launch of Innovative Henry Schein ConnectHealth(TM) Collaborative
10. Henry Schein Disaster Relief Hotline Stands Ready to Support Dental, Medical and Animal Health Customers
11. Henry Schein to Present at the Goldman Sachs 31st Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Jan. 23, 2015  HyGreen, Inc., a leader in hand ... with RCA Medical, a subsidiary of Ascendis Health Limited, ... Each year, hundreds of millions of patients around ... organisms are transmitted from patient to patient via the ...
(Date:1/23/2015)... N.Y. , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. ... its Phase I trial of Lixte,s lead compound, LB‑100, is ... John S. Kovach , M.D., the founder ... planned to be completed at a single site. Accrual of ...
(Date:1/23/2015)... Jan. 23, 2015  CytoSorbents Corporation (NASDAQ CM: CTSO), ... extracorporeal cytokine adsorber to reduce deadly inflammation in ... of $385,642, net of transaction costs, in non-dilutive ... Business Tax Certificate Transfer Program sponsored by the ...
Breaking Medicine Technology:HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3
(Date:1/22/2015)... (PRWEB) January 22, 2015 For over 20 years, ... Oceanside and Vista area has treated just about every ... personal injury circumstances. And for those same twenty-plus years, the ... of all those injuries with the best possible doctor. ...
(Date:1/22/2015)... A study recently published in ... Medicine & Science in Sports & Exercise shows ... reduce gastrointestinal (GI) problems associated with physical strain ... the double-blind, placebo-controlled study took 10 grams of ...
(Date:1/22/2015)... 2015 IsoComforter, Inc. has introduced the most ... IsoTube design to treat specific body parts and muscle groups. ... and easy to use patented cold therapy machine with the ... orthopedic and muscle injuries. IsoComforter has become the industry ...
(Date:1/22/2015)... 22, 2015 EBSCO Information Services ... expanding their relationship in an effort to further promote visibility ... While EBSCO has long made AMA journals available via its ... for The JAMA Network. , Long known as ...
(Date:1/22/2015)... has released a new blog post presenting a list of vehicles ... , Some types of vehicles cannot be covered under an ... post to see if their vehicle qualifies for auto insurance coverage. ... the cars that cannot be covered by a plan. Clients have ...
Breaking Medicine News(10 mins):Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2
... Pharmaceuticals, Inc., an,innovative biotechnology company focusing on ... that it has appointed Linda Hogan as ... Hogan will apply more,than 25 years of ... drive CoLucid,s business development strategies. She will,lead ...
... Conn., Oct. 28 This November, Philips Norelco,will ... awareness,for prostate cancer, a disease that affects one ... as November, has emerged as an annual,global ",Mo,-vement" ... sole,beneficiary of these funds in the U.S. is ...
... device and finance ... background., ... point-of-care robotic systems for the fabrication and,tracking of customized, nano-material-based wound ... officer. Coughlen,joined the PolyRemedy management team on October 14, 2008, and ...
... eSolution" to clinical ... ... software company,focused on developing web-based integrated clinical trials management,systems (CTMS), ... contract research organization (CRO) and ECG core,lab Spacelabs Healthcare Clinical ...
... 28 /Xinhua-PRNewswire-FirstCall/ -- Golden Meditech,Company Limited ("Golden Meditech" ... today that the Group has increased shareholding in ... listed on,Australia Stock Exchange, to 18.9%, and became ... 2.4 million Australian Dollars,(equivalent to HK$12 million)., ...
... Brain Injury Association (CALBIA), a non-profit membership ... those affected by brain injury, together with the ... representing individuals sustaining traumatic brain injury , ... nation’s most important professional medical/legal conferences dealing with ...
Cached Medicine News:Health News:CoLucid Pharmaceuticals Names Linda Hogan VP of Business Development 2Health News:CoLucid Pharmaceuticals Names Linda Hogan VP of Business Development 3Health News:Philips Norelco Encourages Americans to Change the Face of Men's Health: Grow a Moustache This November and Raise Awareness for Prostate Cancer Research 2Health News:Philips Norelco Encourages Americans to Change the Face of Men's Health: Grow a Moustache This November and Raise Awareness for Prostate Cancer Research 3Health News:Philips Norelco Encourages Americans to Change the Face of Men's Health: Grow a Moustache This November and Raise Awareness for Prostate Cancer Research 4Health News:PolyRemedy Hires Gary Coughlen as CFO 2Health News:ECRFPlus Achieves Milestone Multimillion Dollar Enterprise Agreement With CRO and Launches e-CRF+(TM): a CTMS and EDC Web Platform With ECG Analysis and Cardiac Safety Module. 2Health News:ECRFPlus Achieves Milestone Multimillion Dollar Enterprise Agreement With CRO and Launches e-CRF+(TM): a CTMS and EDC Web Platform With ECG Analysis and Cardiac Safety Module. 3Health News:ECRFPlus Achieves Milestone Multimillion Dollar Enterprise Agreement With CRO and Launches e-CRF+(TM): a CTMS and EDC Web Platform With ECG Analysis and Cardiac Safety Module. 4Health News:Golden Meditech Increases Stakes in Cordlife, Largest Cord Blood Bank Operator in Southeast Asia 2Health News:California Brain Injury Association and Scarlett Law Group Conduct Medical/Legal Conference on Traumatic Brain Injury November 21 - 23rd, 2008 2Health News:California Brain Injury Association and Scarlett Law Group Conduct Medical/Legal Conference on Traumatic Brain Injury November 21 - 23rd, 2008 3
To maintain the conjunctival cul-de-sacs after enucleation or evisceration without hindering lid closure....
To maintain the conjunctival cul-de-sacs after enucleation or evisceration without hindering lid closure....
... plugs are coated with a ... that makes the surface slick ... and to prevent debris from ... partial occlusion. For partial stenosis. ...
With side bite Instrument recommended to catch the polypropylene thread in the nose....
Medicine Products: